期刊文献+

上皮细胞黏附分子、CD24在胃癌组织的表达及临床意义 被引量:3

Clinical significance of immunohistochemically detecting epithelial cell adhesion molecule, CD24 ex- pression in human gastric cancer
原文传递
导出
摘要 目的检测74例胃癌组织中上皮细胞黏附分子(EPCAM)、CD24的表达,探讨其与胃癌临床病理资料之间的关系,预测阳性表达的预后。方法应用免疫组织化学二步法检测74例经手术切除并有明确病理诊断为胃癌标本中EPCAM、CD24的表达。分析74例胃癌临床病理资料。全组患者100%随访,结合表达阳性率对随访结果进行预后分析。结果EPCAM阳性45例,阳性率60.81%;CD24阳性47例,阳性率63.51%。EPCAM+CD24+共40例,阳性率54.05%;EPCAM与肿瘤浸润深度、WHO组织学分型、脏器受侵犯与否有关;CD24与浸润深度、肿瘤位置、分化程度有关;EPCAM+CD24+与浸润深度、肿瘤位置、分化程度、脏器受侵犯与否有关。EPCAM+、CD24+及EPCAM+CD44+患者生存率下降。结论EPCAM、CD24在胃癌组织中表达阳性率高,可作为初筛实验;EPCAM+、CD24+及EPCAM+CD24+均与胃癌浸润深度有关;EPCAM+、CD24+及EPCAM+CD24+生存率下降,死亡率高。 Objective Detect the expressions of epithelial cell adhesion molecule( EPCAM ) and CD24 in 74 gastric cancer patients to analyze the relationship between the expressions of this and the clini- eopathologieal data and predict the prognosis. Methods Detect the expressions of EPCAM and CD24 in 74 gastric cancer patients who took the surgical excision and were pathologically diagnosed as gastric cancer u- sing the immunohistochemistry. Analyze the elinicopathological data and the protein expressions. Results 45 patients ( 60. 81% ) are EPCAM positive; 47 patients ( 63.51% ) are CD24 positive; 40 patients (54. 05% ) are both EPCAM and CD24 positive. EPCAM expression is correlated with depth of tumor infil- tration, WHO histological typing and viscera invasion ; CD24 expression is correlated with the depth of infil- tration,location of the tumor, differentiation grade;EPCAM + , CD24 + expression positive are correlated with depth of infihration,location of the tumor, differentiation grade and viscera invasion (P 〈 0. 05 ). The sur- vival rate declined in EPCAM + ,CD24 + and EPCAM + CD24 + . Conclusion The positive rate of EPCAM, CD24 expression is high in gastric cancer tissue and can be used as primary screening test;EPCAM + and CD24 + expressions are correlated with the depth of infiltration. EPCAM + , CD24 + and EPCAM + CD24 + have lower survival rate and higher mortality rate.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2012年第9期1831-1833,共3页 Chinese Journal of Experimental Surgery
基金 广东省自然科学基金资助项目(9151008901000119) 黄埔区科技计划资助项目(2009031) 广东省科技计划资助项目(20098030801112)
关键词 胃癌 上皮细胞黏附分子 CD24 浸润 Gastric carcinoma Epithelial cell adhesion molecule CD24 Infiltration
  • 相关文献

参考文献14

二级参考文献38

  • 1周静,赵刚,刘涛,王春友.实体肿瘤干细胞的研究进展[J].中华实验外科杂志,2006,23(1):122-123. 被引量:24
  • 2涂植光.依托现代科学管理和技术 开展肿瘤标志物研究和应用[J].中华检验医学杂志,2006,29(4):289-292. 被引量:15
  • 3庄建良,苏子剑,许荣誉.CD24与肿瘤侵袭转移的关系[J].国际病理科学与临床杂志,2006,26(5):387-390. 被引量:13
  • 4G.Kristiansen, M.Sammar, P.Ahevogt.Tumor biological aspects of CD24, amucin-like adhesion molecule [J].Journal of Molecular Histology, 2004,35(3): 255-262.
  • 5Baumann P, Cremers N, Kroese F.et al.CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis[J].Cancer Res, 2005,65 (23) : 10783-10793.
  • 6Kristiansen G, Winzer K J, Mayordomo E, et al. CD24 expression is a new prognostic marker in breast cancer[J].Clin Cancer Res, 2003,9 ( 13 ) : 4906-4913.
  • 7Kristiansen G,Denkert C,et al. CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival[J]. AM J Pathol,2002,161 (4) : 1215-1221.
  • 8Jung K C,Seo J N, Kim TW, et al. CD24 Expressionin in gastric adenocarcinoma is associated with tumor invasiveness[J]. Korean J Pathol, 2004,38(6) : 388-393.
  • 9Chou YY, Jeng YM, Lee TT, et al. Cytoplasmic CD24 Expression Is a Novel Prognostic Factor in Diffuse-Type Gastric adenocarcinoma[J]. Ann Surg Oncol, 2007,14(10) :2748-2758.
  • 10Benkerrou M,Jais J P,Leblond V,et al.Anti-B-cell momoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder : Prognostic factors and long-term outcome[J]. Blood, 1998,92 ( 9 ) : 3137-3145.

共引文献12

同被引文献41

  • 1郭星,史艳春,费声重,潘子民.下咽癌颈淋巴转移相关因素的研究[J].中华耳鼻咽喉头颈外科杂志,2005,40(10):779-783. 被引量:28
  • 2Flatmark K,Borgen E,Nesland JM,et al.Disseminated tumour cells as a prognostic biomarker in colorectal cancer.Br J Cancer,2011,104(9):1434-1439.
  • 3Schulze K,Gasch C,Staufer K,et al.Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma.Int J Cancer,2013,133(9):2165-2171.
  • 4Soysal SD,Muenst S,Barbie T,et al.EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2(+),basal-like,and HER2 intrinsic subtypes of breast cancer.Br J Cancer,2013,108(7):1480-1487.
  • 5van der Gun BT,Melchers LJ,Ruiters MH,et al.EpCAM in carcinogenesis:the good,the bad or the ugly.Carcinogenesis,2010,31 (11):1913-1921.
  • 6Yanamoto S,Kawasaki G,Yoshitomi I,et al.Clinicopathologic significance of EpCAM expression in squamous cell carcinoma of the tongue and its possibility as a potential target for tongue cancer gene therapy.Oral Oncol,2007,43(9):869-877.
  • 7Hwang EYC,Yu CH,Cheng SJ,et al.Decreased expression of Ep-CAM protein is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.Joumal of oral pathology & medicine,2009,38(1):87-93.
  • 8Inoue H,Ohnishi Y,Nakajima M,et al.A novel function of EpCAM in oral squamous cell carcinoma cells under anchorageindependent conditions.Int J Oncol,2011,39(6):1401-1405.
  • 9Osta WA,Chen Y,Mikhitarian K,et al.EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy.Cancer Res,2004,64(16):5818-5824.
  • 10Nubel T,Preobraschenski J,Tuncay H,et al.Claudin-7 regulates EpCAM-mediated functions in tumor progression.Mol Cancer Res,2009,7 (3):285-299.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部